5-Bromo-2-iodothiazole

Catalog No.: 
ACNYJG346
CAS No.: 
108306-64-5
Molecular Formula: 
C3HBrINS
Molecular Weight: 
289.92
5-Bromo-2-iodothiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$228.00In stockIn stock
250mg97%$365.00In stockIn stock
1g97%$908.00In stockIn stock
5g97%$3313.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-iodothiazole
IUPAC Name5-bromo-2-iodothiazole
MDL No.MFCD09909654
Molecular FormulaC3HBrINS
Molecular Weight289.92
SMILESIC1=NC=C(Br)S1
InChI KeyKYEQBVRCNVCFOF-UHFFFAOYSA-N
Synonym5-BROMO-2-IODOTHIAZOLE;Thiazole, 5-bromo-2-iodo-;5-bromo-2-iodo-1,3-thiazole
CAS No.108306-64-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNYJG346 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNKGV615 route compound structure diagram
    ACNKGV6154175-78-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNYJG346 route product structure diagram
    ACNYJG346108306-64-5In Stock
Inquiry

2. ACNYJG346 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGLFX394 route compound structure diagram
    ACGLFX394133692-18-9In Stock
  2. Then
  3. ACNYJG346 route product structure diagram
    ACNYJG346108306-64-5In Stock
Inquiry

3. ACNYJG346 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNYJG346 route compound structure diagram
    ACNYJG346108306-64-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNYJG346 route product structure diagram
    ACNYJG346108306-64-5In Stock
Inquiry

Comments (0)